Loading...

Edwin Charlebois, PhD, MPH

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-476-6241
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, BerklelyBA06/1984Genetics
    Univewrsity of California, Berkeley, School of Public HealthMPH06/1990Epidemiology & Biostatistics
    University of California, Berkeley, School of Public HealthPhD12/1998Epidemiology
    University of California, San Francisco, Center for AIDS Prevention StudiesFellowship06/1998HIV/AIDS Research

    Collapse Overview 
    Collapse Overview
    As a senior scientist at the UCSF Center for AIDS Prevention Studies (CAPS) my research program focuses on the epidemiology and prevention of HIV infection and its consequences. Overarching this focus are translational science efforts to improve the methodology and evaluation of research and interventions aimed at controlling and eventually eliminating the domestic and international spread of HIV.

    Domestic HIV Research: My most recent domestic HIV prevention research is an evaluation of the potential effect of expanded ART and HIV testing strategies on reducing the number of new HIV infections in San Francisco. In this computational biology modeling paper published in CID in 2011 (with an accompanying editorial) we estimated significant reductions in new HIV infections are likely with expanded HIV treatment of those already in care and even greater gains with more frequent at-risk community HIV testing. This research along with the results of recent clinical trials were cited as evidence for a change in treatment policy in San Francisco to offer ART to all HIV infected persons. Our studies relate well with a recent editorial we published in 2010 in Archives of Internal Medicine wherein we highlight the importance of linking HIV infected persons into care and the associated potential HIV prevention benefits.

    Another priority research area for me is the development of methods for the evaluation of combination HIV prevention interventions. Combination HIV prevention interventions are specifically called for in the US National HIV/AIDS Strategy (NHAS) and specific evaluation methods for them have been identified as significant scientific gap in our recently published 2011 editorial in JAIDS on setting the NIH research agenda for the NHAS. Specifically, I have received developmental funding to pursue novel evaluation methods for community-level combination HIV prevention interventions that involve surveillance measurements of community HIV viral load, intervention process measures and structural equation modeling. In addition I will be co-directing a research team assisting in the evaluation of the San Francisco implementation of the HRSA and CDC’s 12-city project – a combination HIV prevention intervention comprising 14 interventions. In the fall of 2011 I will be leading a national round-table on the state-of-the-art and future research directions for evaluation methods for combination HIV prevention interventions to be hosted by the UCSF Center for AIDS Prevention Studies.

    International HIV Research: Internationally, my research focus is on HIV and co-infections/interaction with Tuberculosis and Malaria. Primarily working in East Africa, I am Principal Investigator of three NIH sponsored grants and co-investigator on several more. I am currently studying effective strategies for diagnosing HIV among outpatient TB evaluation patients and their family and household members in a 2,000 person randomized trial of home-based versus TB clinic based HIV testing and utilization of same-day rapid HIV tests. I am also involved in studying interactions between HIV protease inhibitor treatment and malaria incidence in two additional randomized HIV treatment trials among HIV infected children and HIV infected pregnant women. On a broader scale I am co-leading the development of a three country research collaboration, SEARCH (Sustainable East Africa Research in Community Health) to study the community level effectiveness of a program of community-wide HIV testing and universal HIV treatment to all HIV infected persons and its effect on HIV, TB, Malaria incidence and community economic and educational productivity. My area of research within the collaboration focuses on the 40 community-cluster randomized design, its HIV specific end-points of HIV incidence and community HIV viral load, and the development and evaluation of streamlined HIV care and evaluation.

    Training the Next Generation of HIV Scientists: An important part of my research program is training and mentoring the next generation of HIV scientists. As the principal investigator of 2 large international data management and statistical support cores (one for a NICHD supported program project, and one for a NIAID funded International Center for Excellence in Malaria Research, ICEMR) – I am able to organize and support the cores as a resource for training and mentoring post-doctoral researchers and medical students in international HIV and clinical research. Through individual level research mentorship, a weekly international investigators seminar held in the US, the UCSF CAPS Traineeship in AIDS Prevention Studies (TAPS) program, and affiliated NIH K training grants, I supervise and assist between 3-5 trainees annually in the development of individual research projects, and epidemiologic and biostatistical training.

    Collapse Research 
    Collapse Research Activities and Funding
    Novel Evaluation Methods for Multi-Level/Combination HIV Prevention Interventions
    NIH/NIMH R21MH098811Sep 11, 2012 - Jun 30, 2014
    Role: Principal Investigator
    Structural Alcohol Intervention to Reduce HIV Risk Behavior
    NIH/NIAAA R21AA020467Sep 1, 2012 - Aug 31, 2014
    Role: Principal Investigator
    Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda
    NIH U19AI089674Jul 1, 2010 - Jun 30, 2017
    Role: Co-Investigator
    Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa
    NIH/NICHD P01HD059454Aug 1, 2008 - Jun 30, 2018
    Role: Co-Investigator
    Family-Based HIV VCT in Patients at Risk for TB
    NIH/NIMH R01MH075637May 10, 2006 - Dec 31, 2012
    Role: Principal Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000083Oct 1, 1974 - Sep 29, 2006
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Global Health
    Collapse Websites
    Collapse In The News
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Improved Viral Suppression with Streamlined Care in the SEARCH Study. . 2020 Sep 24. Hickey MD, Ayieko J, Kwarisiima D, Opel FJ, Owaraganise A, Balzer LB, Chamie G, Jain V, Peng J, Camlin C, Charlebois ED, Cohen CR, Bukusi EA, Kamya MR, Petersen ML, Havlir DV. PMID: 32991337.
      View in: PubMed   Mentions:
    2. Far from MCAR: Obtaining Population-level Estimates of HIV Viral Suppression. Epidemiology. 2020 Sep; 31(5):620-627. Balzer LB, Ayieko J, Kwarisiima D, Chamie G, Charlebois ED, Schwab J, van der Laan MJ, Kamya MR, Havlir DV, Petersen ML. PMID: 32452912.
      View in: PubMed   Mentions:    Fields:    
    3. Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial. AIDS. 2020 07 15; 34(9):1407-1415. Kabami J, Balzer LB, Saddiki H, Ayieko J, Kwarisiima D, Atukunda M, Charlebois ED, Clark TD, Koss CA, Ruel T, Bukusi EA, Cohen CR, Musoke P, Petersen ML, Havlir DV, Kamya MR, Chamie G. PMID: 32472768.
      View in: PubMed   Mentions:    Fields:    
    4. Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study. AIDS Behav. 2020 Jul; 24(7):2149-2162. Camlin CS, Koss CA, Getahun M, Owino L, Itiakorit H, Akatukwasa C, Maeri I, Bakanoma R, Onyango A, Atwine F, Ayieko J, Kabami J, Mwangwa F, Atukunda M, Owaraganise A, Kwarisiima D, Sang N, Bukusi EA, Kamya MR, Petersen ML, Cohen CR, Charlebois ED, Havlir DV. PMID: 31955361.
      View in: PubMed   Mentions: 1     Fields:    
    5. Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral Therapy. Curr Dev Nutr. 2020 May; 4(5):nzaa075. Finkelstein JL, Herman HS, Plenty A, Mehta S, Natureeba P, Clark TD, Kamya MR, Ruel T, Charlebois ED, Cohan D, Havlir D, Young SL. PMID: 32440638.
      View in: PubMed   Mentions:
    6. Drought and intimate partner violence towards women in 19 countries in sub-Saharan Africa during 2011-2018: A population-based study. PLoS Med. 2020 03; 17(3):e1003064. Epstein A, Bendavid E, Nash D, Charlebois ED, Weiser SD. PMID: 32191701.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. The epidemiology of chronic kidney disease (CKD) in rural East Africa: A population-based study. PLoS One. 2020; 15(3):e0229649. Muiru AN, Charlebois ED, Balzer LB, Kwarisiima D, Elly A, Black D, Okiror S, Kabami J, Atukunda M, Snyman K, Petersen M, Kamya M, Havlir D, Estrella MM, Hsu CY. PMID: 32130245.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa. AIDS. 2020 03 01; 34(3):405-413. Puryear SB, Balzer LB, Ayieko J, Kwarisiima D, Hahn JA, Charlebois ED, Clark TD, Cohen CR, Bukusi EA, Kamya MR, Petersen ML, Havlir DV, Chamie G. PMID: 31725431.
      View in: PubMed   Mentions: 1     Fields:    
    9. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study. Lancet HIV. 2020 04; 7(4):e249-e261. Koss CA, Charlebois ED, Ayieko J, Kwarisiima D, Kabami J, Balzer LB, Atukunda M, Mwangwa F, Peng J, Mwinike Y, Owaraganise A, Chamie G, Jain V, Sang N, Olilo W, Brown LB, Marquez C, Zhang K, Ruel TD, Camlin CS, Rooney JF, Black D, Clark TD, Gandhi M, Cohen CR, Bukusi EA, Petersen ML, Kamya MR, Havlir DV. PMID: 32087152.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    10. The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural Uganda. PLoS One. 2020; 15(1):e0228102. Marquez C, Atukunda M, Balzer LB, Chamie G, Kironde J, Ssemmondo E, Ruel TD, Mwangwa F, Tram KH, Clark TD, Kwarisiima D, Petersen M, Kamya MR, Charlebois ED, Havlir DV. PMID: 31995631.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Hypertension testing and treatment in Uganda and Kenya through the SEARCH study: An implementation fidelity and outcome evaluation. PLoS One. 2020; 15(1):e0222801. Heller DJ, Balzer LB, Kazi D, Charlebois ED, Kwarisiima D, Mwangwa F, Jain V, Kotwani P, Chamie G, Cohen CR, Clark TD, Ayieko J, Byonanabye DM, Petersen M, Kamya MR, Havlir D, Kahn JG. PMID: 31940346.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    12. The Influence of Social Networks on Antiretroviral Therapy Initiation Among HIV-Infected Antiretroviral Therapy-Naive Youth in Rural Kenya and Uganda. J Acquir Immune Defic Syndr. 2020 01 01; 83(1):9-15. Brown LB, Balzer LB, Kabami J, Kwarisiima D, Sang N, Ayieko J, Chen Y, Chamie G, Charlebois ED, Camlin CS, Cohen CR, Bukusi E, Kamya MR, Moody J, Havlir DV, Petersen ML. PMID: 31809357.
      View in: PubMed   Mentions:
    13. Pre-exposure Prophylaxis (PrEP) Uptake Among Older Individuals in Rural Western Kenya. J Acquir Immune Defic Syndr. 2019 12 01; 82(4):e50-e53. Olilo WA, Petersen ML, Koss CA, Wafula E, Kwarisiima D, Kadede K, Clark TD, Cohen CR, Bukusi EA, Kamya MR, Charlebois ED, Havlir DV, Ayieko J. PMID: 31490343.
      View in: PubMed   Mentions:
    14. Machine learning to identify persons at high-risk of HIV acquisition in rural Kenya and Uganda. Clin Infect Dis. 2019 Nov 07. Balzer LB, Havlir DV, Kamya MR, Chamie G, Charlebois ED, Clark TD, Koss CA, Kwarisiima D, Ayieko J, Sang N, Kabami J, Atukunda M, Jain V, Camlin CS, Cohen CR, Bukusi EA, van der Laan M, Petersen ML. PMID: 31697383.
      View in: PubMed   Mentions: 3     Fields:    
    15. Mobility and its Effects on HIV Acquisition and Treatment Engagement: Recent Theoretical and Empirical Advances. Curr HIV/AIDS Rep. 2019 08; 16(4):314-323. Camlin CS, Charlebois ED. PMID: 31256348.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa. N Engl J Med. 2019 07 18; 381(3):219-229. Havlir DV, Balzer LB, Charlebois ED, Clark TD, Kwarisiima D, Ayieko J, Kabami J, Sang N, Liegler T, Chamie G, Camlin CS, Jain V, Kadede K, Atukunda M, Ruel T, Shade SB, Ssemmondo E, Byonanebye DM, Mwangwa F, Owaraganise A, Olilo W, Black D, Snyman K, Burger R, Getahun M, Achando J, Awuonda B, Nakato H, Kironde J, Okiror S, Thirumurthy H, Koss C, Brown L, Marquez C, Schwab J, Lavoy G, Plenty A, Mugoma Wafula E, Omanya P, Chen YH, Rooney JF, Bacon M, van der Laan M, Cohen CR, Bukusi E, Kamya MR, Petersen M. PMID: 31314966.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    17. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial. Lancet Infect Dis. 2019 09; 19(9):962-972. Muhindo MK, Jagannathan P, Kakuru A, Opira B, Olwoch P, Okiring J, Nalugo N, Clark TD, Ruel T, Charlebois E, Feeney ME, Havlir DV, Dorsey G, Kamya MR. PMID: 31307883.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    18. Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda. AIDS Care. 2020 01; 32(1):119-127. Tram KH, Mwangwa F, Chamie G, Atukunda M, Owaraganise A, Ayieko J, Jain V, Clark TD, Kwarisiima D, Petersen ML, Kamya MR, Charlebois ED, Havlir DV, Marquez C. PMID: 31181961.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Gendered dimensions of population mobility associated with HIV across three epidemics in rural Eastern Africa. Health Place. 2019 05; 57:339-351. Camlin CS, Akullian A, Neilands TB, Getahun M, Bershteyn A, Ssali S, Geng E, Gandhi M, Cohen CR, Maeri I, Eyul P, Petersen ML, Havlir DV, Kamya MR, Bukusi EA, Charlebois ED. PMID: 31152972.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    20. Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study. BMC Public Health. 2019 May 06; 19(1):511. Kwarisiima D, Atukunda M, Owaraganise A, Chamie G, Clark T, Kabami J, Jain V, Byonanebye D, Mwangwa F, Balzer LB, Charlebois E, Kamya MR, Petersen M, Havlir DV, Brown LB. PMID: 31060545.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    21. Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda. J Int AIDS Soc. 2019 04; 22(4):e25276. Mayer CM, Owaraganise A, Kabami J, Kwarisiima D, Koss CA, Charlebois ED, Kamya MR, Petersen ML, Havlir DV, Jewell BL. PMID: 31037845.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    22. A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya. J Acquir Immune Defic Syndr. 2019 04 01; 80(4):414-422. Ayieko J, Petersen ML, Charlebois ED, Brown LB, Clark TD, Kwarisiima D, Kamya MR, Cohen CR, Bukusi EA, Havlir DV, Van Rie A. PMID: 30807481.
      View in: PubMed   Mentions:
    23. A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2019 Apr 1; 80(4):414-422. James Ayieko, Maya L. Petersen, Edwin D. Charlebois, Lillian B. Brown, Tamara D. Clark, Dalsone Kwarisiima, Moses R. Kamya, Craig R. Cohen, Elizabeth A. Bukusi, Diane V. Havlir, Annelies Van Rie. .
      View in: Publisher Site   Mentions:
    24. Alcohol Consumption and Management Strategies Among Gay Bar Patrons in San Francisco and Oakland, CA. Contemporary Drug Problems. 2019 Mar 1; 46(1):22-40. Jessica Lin, Jennifer Hecht, Albert H. Plenty, Bob Siedle-Khan, Sophia Zamudio-Haas, Alicia Ayala, Edwin D. Charlebois. .
      View in: Publisher Site   Mentions:
    25. Alcohol Consumption and Management Strategies Among Gay Bar Patrons in San Francisco and Oakland, CA. Contemporary Drug Problems. 2019; 46(1):22-40. Lin J, Hecht J, Plenty AH, Siedle-Khan B, Zamudio-Haas S, Ayala A, Charlebois ED.. View Publication.
    26. Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis. PLoS One. 2019; 14(1):e0210126. Brown LB, Getahun M, Ayieko J, Kwarisiima D, Owaraganise A, Atukunda M, Olilo W, Clark T, Bukusi EA, Cohen CR, Kamya MR, Petersen ML, Charlebois ED, Havlir DV, Camlin CS. PMID: 30673744.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. Mobile, Population-wide, Hybrid HIV Testing Strategy Increases Number of Children Tested in Rural Kenya and Uganda. Pediatr Infect Dis J. 2018 12; 37(12):1279-1281. Ayieko J, Chamie G, Balzer L, Kwarisiima D, Kabami J, Sang N, Cohen CR, Bukusi EA, Clark TD, Plenty A, Charlebois ED, Petersen M, Kamya M, Havlir DV, Ruel T. PMID: 30199482.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    28. Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda. Clin Infect Dis. 2018 11 28; 67(12):1853-1860. Koss CA, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Balzer LB, Plenty A, Sang N, Kabami J, Ruel TD, Black D, Camlin CS, Cohen CR, Bukusi EA, Clark TD, Charlebois ED, Petersen ML, Kamya MR, Havlir DV. PMID: 29741594.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    29. Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys. AIDS. 2018 09 24; 32(15):2179-2188. Shade SB, Osmand T, Luo A, Aine R, Assurah E, Mwebaza B, Mwai D, Owaraganise A, Mwangwa F, Ayieko J, Black D, Brown LB, Clark TD, Kwarisiima D, Thirumurthy H, Cohen CR, Bukusi EA, Charlebois ED, Balzer L, Kamya MR, Petersen ML, Havlir DV, Jain V. PMID: 30134294.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    30. "Hurdles on the path to 90-90-90 and beyond": Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat. PLoS One. 2018; 13(8):e0202990. Ayieko J, Brown L, Anthierens S, Van Rie A, Getahun M, Charlebois ED, Petersen ML, Clark TD, Kamya MR, Cohen CR, Bukusi EA, Havlir DV, Camlin CS. PMID: 30161172.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial. PLoS Med. 2018 07; 15(7):e1002606. Jagannathan P, Kakuru A, Okiring J, Muhindo MK, Natureeba P, Nakalembe M, Opira B, Olwoch P, Nankya F, Ssewanyana I, Tetteh K, Drakeley C, Beeson J, Reiling L, Clark TD, Rodriguez-Barraquer I, Greenhouse B, Wallender E, Aweeka F, Prahl M, Charlebois ED, Feeney ME, Havlir DV, Kamya MR, Dorsey G. PMID: 30016328.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    32. Population mobility associated with higher risk sexual behaviour in eastern African communities participating in a Universal Testing and Treatment trial. J Int AIDS Soc. 2018 07; 21 Suppl 4:e25115. Camlin CS, Akullian A, Neilands TB, Getahun M, Eyul P, Maeri I, Ssali S, Geng E, Gandhi M, Cohen CR, Kamya MR, Odeny T, Bukusi EA, Charlebois ED. PMID: 30027668.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    33. High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial. PLoS One. 2018; 13(6):e0198912. Jakubowski A, Snyman K, Kwarisiima D, Sang N, Burger R, Balzer L, Clark T, Chamie G, Shade S, Cohen C, Bukusi E, Charlebois E, Kamya M, Petersen M, Havlir D, Thirumurthy H. PMID: 29944678.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    34. Effect of a Patient-Centered Phone Call by a Clinical Officer at Time of HIV Testing on Linkage to Care in Rural Kenya. Open Forum Infect Dis. 2018 Jun 01; 5(6):ofy126. Ayieko J, Petersen ML, van Rie A, Wafula E, Opudo W, Clark TD, Kamya MR, Balzer LB, Cohen CR, Bukusi EA, Charlebois ED, Havlir DV. PMID: 29977971.
      View in: PubMed   Mentions:
    35. Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda. PLoS One. 2018; 13(2):e0192666. Chamie G, Kato-Maeda M, Emperador DM, Wandera B, Mugagga O, Crandall J, Janes M, Marquez C, Kamya MR, Charlebois ED, Havlir DV. PMID: 29438413.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care. . 2017 Dec 15; 76(5):e115-e117. Tram KH, Mwangwa F, Atukunda M, Owaraganise A, Ayieko J, Plenty A, Kwariisima D, Clark TD, Petersen ML, Charlebois ED, Kamya MR, Chamie G, Havlir DV, Marquez C. PMID: 28885271.
      View in: PubMed   Mentions:
    37. Understanding uptake of an intervention to accelerate antiretroviral therapy initiation in Uganda via qualitative inquiry. J Int AIDS Soc. 2017 12; 20(4). Semitala FC, Camlin CS, Wallenta J, Kampiire L, Katuramu R, Amanyire G, Namusobya J, Chang W, Kahn JG, Charlebois ED, Havlir DV, Kamya MR, Geng EH. PMID: 29206357.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    38. Redemption of the "spoiled identity:" the role of HIV-positive individuals in HIV care cascade interventions. J Int AIDS Soc. 2017 12; 20(4). Camlin CS, Charlebois ED, Geng E, Semitala F, Wallenta J, Getahun M, Kampiire L, Bukusi EA, Sang N, Kwarisiima D, Clark TD, Petersen ML, Kamya MR, Havlir DV. PMID: 29210185.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. Gaps in the Child Tuberculosis Care Cascade in 32 Rural Communities in Uganda and Kenya. J Clin Tuberc Other Mycobact Dis. 2017 Dec; 9:24-29. Mwangwa F, Chamie G, Kwarisiima D, Ayieko J, Owaraganise A, Ruel TD, Plenty A, Tram KH, Clark TD, Cohen CR, Bukusi EA, Petersen M, Kamya MR, Charlebois ED, Havlir DV, Marquez C. PMID: 29291251.
      View in: PubMed   Mentions:
    40. Impact of a Structural Intervention to Address Alcohol Use Among Gay Bar Patrons in San Francisco: The PACE Study. AIDS Behav. 2017 Nov; 21(Suppl 2):193-202. Charlebois ED, Plenty AH, Lin J, Ayala A, Hecht J. PMID: 28840396.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Correction to: Impact of a Structural Intervention to Address Alcohol Use Among Gay Bar Patrons in San Francisco: The PACE Study. AIDS Behav. 2017 11; 21(Suppl 2):203. Charlebois ED, Plenty AH, Lin J, Ayala A, Carrico AW, Hecht J. PMID: 29058162.
      View in: PubMed   Mentions: 1     Fields:    
    42. Predictors of Retention in HIV Care Among Youth (15-24) in a Universal Test-and-Treat Setting in Rural Kenya. J Acquir Immune Defic Syndr. 2017 09 01; 76(1):e15-e18. Brown LB, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Jain V, Ruel T, Clark T, Black D, Chamie G, Bukusi EA, Cohen CR, Kamya MR, Petersen ML, Charlebois ED, Havlir DV. PMID: 28394821.
      View in: PubMed   Mentions:
    43. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya. J Int AIDS Soc. 2017 07 21; 20(Suppl 4):21673. Kwarisiima D, Kamya MR, Owaraganise A, Mwangwa F, Byonanebye DM, Ayieko J, Plenty A, Black D, Clark TD, Nzarubara B, Snyman K, Brown L, Bukusi E, Cohen CR, Geng EH, Charlebois ED, Ruel TD, Petersen ML, Havlir D, Jain V. PMID: 28770596.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    44. Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women. J Infect Dis. 2017 07 01; 216(1):29-35. Natureeba P, Kakuru A, Muhindo M, Ochieng T, Ategeka J, Koss CA, Plenty A, Charlebois ED, Clark TD, Nzarubara B, Nakalembe M, Cohan D, Rizzuto G, Muehlenbachs A, Ruel T, Jagannathan P, Havlir DV, Kamya MR, Dorsey G. PMID: 28329368.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    45. Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa. JAMA. 2017 Jun 06; 317(21):2196-2206. Petersen M, Balzer L, Kwarsiima D, Sang N, Chamie G, Ayieko J, Kabami J, Owaraganise A, Liegler T, Mwangwa F, Kadede K, Jain V, Plenty A, Brown L, Lavoy G, Schwab J, Black D, van der Laan M, Bukusi EA, Cohen CR, Clark TD, Charlebois E, Kamya M, Havlir D. PMID: 28586888.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    46. Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda. . 2017 Mar 01; 74(3):279-284. Koss CA, Natureeba P, Kwarisiima D, Ogena M, Clark TD, Olwoch P, Cohan D, Okiring J, Charlebois ED, Kamya MR, Havlir DV. PMID: 27828878.
      View in: PubMed   Mentions:
    47. Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis. Lancet HIV. 2017 03; 4(3):e122-e133. Jain V, Petersen ML, Liegler T, Byonanebye DM, Kwarisiima D, Chamie G, Sang N, Black D, Clark TD, Ladai A, Plenty A, Kabami J, Ssemmondo E, Bukusi EA, Cohen CR, Charlebois ED, Kamya MR, Havlir DV. PMID: 27989576.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    48. Growth Recovery Among HIV-infected Children Randomized to Lopinavir/Ritonavir or NNRTI-based Antiretroviral Therapy. Pediatr Infect Dis J. 2016 12; 35(12):1329-1332. Achan J, Kakuru A, Ikilezi G, Mwangwa F, Plenty A, Charlebois E, Young S, Havlir D, Kamya M, Ruel T. PMID: 27580060.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    49. High levels of retention in care with streamlined care and universal test and treat in East Africa. AIDS. 2016 11 28; 30(18):2855-2864. Brown LB, Havlir DV, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Jain V, Ruel T, Clark T, Chamie G, Bukusi EA, Cohen CR, Kamya MR, Petersen ML, Charlebois ED. PMID: 27603290.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    50. Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa. . 2016 Nov 01; 73(3):e39-e45. Chang W, Chamie G, Mwai D, Clark TD, Thirumurthy H, Charlebois ED, Petersen M, Kabami J, Ssemmondo E, Kadede K, Kwarisiima D, Sang N, Bukusi EA, Cohen CR, Kamya M, Havlir DV, Kahn JG. PMID: 27741031.
      View in: PubMed   Mentions:
    51. Implementation and Operational Research: Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural Uganda. . 2016 Nov 01; 73(3):e46-e50. Ssemmondo E, Mwangwa F, Kironde JL, Kwarisiima D, Clark TD, Marquez C, Charlebois ED, Petersen ML, Kamya MR, Havlir DV, Chamie G. PMID: 27741032.
      View in: PubMed   Mentions:
    52. Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya. AIDS. 2016 09 10; 30(14):2121-6. Kadede K, Ruel T, Kabami J, Ssemmondo E, Sang N, Kwarisiima D, Bukusi E, Cohen CR, Liegler T, Clark TD, Charlebois ED, Petersen ML, Kamya MR, Havlir DV, Chamie G. PMID: 27258399.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    53. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. Lancet HIV. 2016 11; 3(11):e539-e548. Amanyire G, Semitala FC, Namusobya J, Katuramu R, Kampiire L, Wallenta J, Charlebois E, Camlin C, Kahn J, Chang W, Glidden D, Kamya M, Havlir D, Geng E. PMID: 27658873.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    54. Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda. Pediatr Infect Dis J. 2016 May; 35(5):524-9. Marquez C, Chamie G, Achan J, Luetkemeyer AF, Kyohere M, Okiring J, Dorsey G, Kamya MR, Charlebois ED, Havlir DV. PMID: 26771662.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    55. Strengthening universal HIV 'test-and-treat' approaches with social science research. AIDS. 2016 Mar 27; 30(6):969-70. Camlin CS, Seeley J, Viljoen L, Vernooij E, Simwinga M, Reynolds L, Reis R, Plank R, Orne-Gliemann J, McGrath N, Larmarange J, Hoddinott G, Getahun M, Charlebois ED, Bond V. PMID: 26959355.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    56. Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. N Engl J Med. 2016 Mar 10; 374(10):928-39. Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, Opira B, Olwoch P, Ategeka J, Nayebare P, Clark TD, Feeney ME, Charlebois ED, Rizzuto G, Muehlenbachs A, Havlir DV, Kamya MR, Dorsey G. PMID: 26962728.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    57. Brief Report: Food Insufficiency Is Associated With Lack of Sustained Viral Suppression Among HIV-Infected Pregnant and Breastfeeding Ugandan Women. . 2016 Mar 01; 71(3):310-5. Koss CA, Natureeba P, Nyafwono D, Plenty A, Mwesigwa J, Nzarubara B, Clark TD, Ruel TD, Achan J, Charlebois ED, Cohan D, Kamya MR, Havlir DV, Young SL. PMID: 26397935.
      View in: PubMed   Mentions:
    58. A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study. Lancet HIV. 2016 Mar; 3(3):e111-9. Chamie G, Clark TD, Kabami J, Kadede K, Ssemmondo E, Steinfeld R, Lavoy G, Kwarisiima D, Sang N, Jain V, Thirumurthy H, Liegler T, Balzer LB, Petersen ML, Cohen CR, Bukusi EA, Kamya MR, Havlir DV, Charlebois ED. PMID: 26939734.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansPHPublic Health
    59. "How can I tell?" Consequences of HIV status disclosure among couples in eastern African communities in the context of an ongoing HIV "test-and-treat" trial. AIDS Care. 2016; 28 Suppl 3:59-66. Maeri I, El Ayadi A, Getahun M, Charlebois E, Akatukwasa C, Tumwebaze D, Itiakorit H, Owino L, Kwarisiima D, Ssemmondo E, Sang N, Kabami J, Clark TD, Petersen M, Cohen CR, Bukusi EA, Kamya M, Havlir D, Camlin CS. PMID: 27421052.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    60. Men "missing" from population-based HIV testing: insights from qualitative research. AIDS Care. 2016; 28 Suppl 3:67-73. Camlin CS, Ssemmondo E, Chamie G, El Ayadi AM, Kwarisiima D, Sang N, Kabami J, Charlebois E, Petersen M, Clark TD, Bukusi EA, Cohen CR, R Kamya M, Havlir D. PMID: 27421053.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansPHPublic Health
    61. Expectations about future health and longevity in Kenyan and Ugandan communities receiving a universal test-and-treat intervention in the SEARCH trial. AIDS Care. 2016; 28 Suppl 3:90-8. Thirumurthy H, Jakubowski A, Camlin C, Kabami J, Ssemmondo E, Elly A, Mwai D, Clark T, Cohen C, Bukusi E, Kamya M, Petersen M, Havlir D, Charlebois ED. PMID: 27421056.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    62. A Framework for Global Collaborative Data Management for Malaria Research. Am J Trop Med Hyg. 2015 Sep; 93(3 Suppl):124-132. Gutierrez JB, Harb OS, Zheng J, Tisch DJ, Charlebois ED, Stoeckert CJ, Sullivan SA. PMID: 26259944.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    63. "I Have Remained Strong Because of That Food": Acceptability and Use of Lipid-Based Nutrient Supplements Among Pregnant HIV-Infected Ugandan Women Receiving Combination Antiretroviral Therapy. AIDS Behav. 2015 Aug; 19(8):1535-47. Young S, Natamba B, Luwedde F, Nyafwono D, Okia B, Osterbauer B, Natureeba P, Johnson L, Michel C, Zheng A, Robine M, Achan J, Charlebois E, Cohan D, Havlir D. PMID: 25416075.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    64. Acceptance of the use of HIV surveillance data for care engagement: national and local community perspectives. . 2015 May 01; 69 Suppl 1:S31-6. Evans D, Van Gorder D, Morin SF, Steward WT, Gaffney S, Charlebois ED. PMID: 25867776.
      View in: PubMed   Mentions:
    65. Examining clinic-based and public health approaches to ascertainment of HIV care status. . 2015 May 01; 69 Suppl 1:S56-62. Christopoulos KA, Scheer S, Steward WT, Barnes R, Hartogensis W, Charlebois ED, Morin SF, Truong HM, Geng EH. PMID: 25867779.
      View in: PubMed   Mentions:
    66. Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women. AIDS. 2015 Apr 24; 29(7):825-30. Koss CA, Natureeba P, Mwesigwa J, Cohan D, Nzarubara B, Bacchetti P, Horng H, Clark TD, Plenty A, Ruel TD, Achan J, Charlebois ED, Kamya MR, Havlir DV, Gandhi M. PMID: 25985404.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    67. Authors' response. Trop Med Int Health. 2015 Jul; 20(7):965-6. Chamie G, Charlebois ED. PMID: 25778797.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    68. The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, Uganda. Pediatr Infect Dis J. 2015 Mar; 34(3):e63-70. Bartelink IH, Savic RM, Dorsey G, Ruel T, Gingrich D, Scherpbier HJ, Capparelli E, Jullien V, Young SL, Achan J, Plenty A, Charlebois E, Kamya M, Havlir D, Aweeka F. PMID: 25742090.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    69. Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach. Trop Med Int Health. 2015 Apr; 20(4):537-45. Chamie G, Wandera B, Marquez C, Kato-Maeda M, Kamya MR, Havlir DV, Charlebois ED. PMID: 25583212.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    70. Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women. AIDS. 2015 Jan 14; 29(2):183-91. Cohan D, Natureeba P, Koss CA, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Gandhi M, Clark TD, Nzarubara B, Achan J, Ruel T, Kamya MR, Havlir DV. PMID: 25426808.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    71. Household food insecurity, maternal nutritional status, and infant feeding practices among HIV-infected Ugandan women receiving combination antiretroviral therapy. Matern Child Health J. 2014 Nov; 18(9):2044-53. Young SL, Plenty AH, Luwedde FA, Natamba BK, Natureeba P, Achan J, Mwesigwa J, Ruel TD, Ades V, Osterbauer B, Clark TD, Dorsey G, Charlebois ED, Kamya M, Havlir DV, Cohan DL. PMID: 24585398.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    72. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy. . 2014 Oct 01; 67(2):128-35. Koss CA, Natureeba P, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Clark TD, Achan J, Ruel T, Nzarubara B, Kamya MR, Havlir DV, Cohan D. PMID: 25072616.
      View in: PubMed   Mentions:
    73. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/µl in rural Uganda. AIDS. 2014 Sep 24; 28(15):2241-9. Jain V, Byonanebye DM, Amanyire G, Kwarisiima D, Black D, Kabami J, Chamie G, Clark TD, Rooney JF, Charlebois ED, Kamya MR, Havlir DV. PMID: 25022596.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    74. Assessing the quality of tuberculosis evaluation for children with prolonged cough presenting to routine community health care settings in rural Uganda. PLoS One. 2014; 9(8):e105935. Marquez C, Davis JL, Katamba A, Haguma P, Ochom E, Ayakaka I, Chamie G, Dorsey G, Kamya MR, Charlebois E, Havlir DV, Cattamanchi A. PMID: 25170875.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    75. Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration. J Trop Pediatr. 2014 Dec; 60(6):434-41. Marquez C, Okiring J, Chamie G, Ruel TD, Achan J, Kakuru A, Kamya MR, Charlebois ED, Havlir DV, Dorsey G. PMID: 25145704.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    76. Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women. J Infect Dis. 2014 Dec 15; 210(12):1938-45. Natureeba P, Ades V, Luwedde F, Mwesigwa J, Plenty A, Okong P, Charlebois ED, Clark TD, Nzarubara B, Havlir DV, Achan J, Kamya MR, Cohan D, Dorsey G. PMID: 24958908.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    77. Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children. Clin Infect Dis. 2014 Aug 01; 59(3):446-53. Kakuru A, Achan J, Muhindo MK, Ikilezi G, Arinaitwe E, Mwangwa F, Ruel T, Clark TD, Charlebois E, Rosenthal PJ, Havlir D, Kamya MR, Tappero JW, Dorsey G. PMID: 24759826.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    78. Virologic and immunologic outcomes of HIV-infected Ugandan children randomized to lopinavir/ritonavir or nonnucleoside reverse transcriptase inhibitor therapy. . 2014 Apr 15; 65(5):535-41. Ruel TD, Kakuru A, Ikilezi G, Mwangwa F, Dorsey G, Rosenthal PJ, Charlebois E, Havlir D, Kamya M, Achan J. PMID: 24326597.
      View in: PubMed   Mentions:
    79. Changes in population HIV RNA levels in Mbarara, Uganda, during scale-up of HIV antiretroviral therapy access. . 2014 Mar 01; 65(3):327-32. Jain V, Byonanebye DM, Liegler T, Kwarisiima D, Chamie G, Kabami J, Petersen ML, Balzer LB, Clark TD, Black D, Thirumurthy H, Geng EH, Charlebois ED, Amanyire G, Kamya MR, Havlir DV. PMID: 24146022.
      View in: PubMed   Mentions:
    80. Evaluating linkage to care for hypertension after community-based screening in rural Uganda. Trop Med Int Health. 2014 Apr; 19(4):459-68. Kotwani P, Balzer L, Kwarisiima D, Clark TD, Kabami J, Byonanebye D, Bainomujuni B, Black D, Chamie G, Jain V, Thirumurthy H, Kamya MR, Geng EH, Petersen ML, Havlir DV, Charlebois ED. PMID: 24495307.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    81. Uptake of community-based HIV testing during a multi-disease health campaign in rural Uganda. PLoS One. 2014; 9(1):e84317. Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, Balzer LB, Petersen ML, Thirumurthy H, Charlebois ED, Kamya MR, Havlir DV. PMID: 24392124.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    82. Epidemiology and awareness of hypertension in a rural Ugandan community: a cross-sectional study. BMC Public Health. 2013 Dec 09; 13:1151. Kotwani P, Kwarisiima D, Clark TD, Kabami J, Geng EH, Jain V, Chamie G, Petersen ML, Thirumurthy H, Kamya MR, Charlebois ED, Havlir DV. PMID: 24321133.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    83. Linkage to HIV care in San Francisco: implications of measure selection. . 2013 Nov 01; 64 Suppl 1:S27-32. Das M, Christopoulos KA, Geckeler D, Huriaux E, Cohen SE, Philip S, Shade S, Moss NJ, Morin SF, Charlebois ED. PMID: 24126446.
      View in: PubMed   Mentions:
    84. Does effective depression treatment alone reduce secondary HIV transmission risk? Equivocal findings from a randomized controlled trial. AIDS Behav. 2013 Oct; 17(8):2765-72. Tsai AC, Mimiaga MJ, Dilley JW, Hammer GP, Karasic DH, Charlebois ED, Sorensen JL, Safren SA, Bangsberg DR. PMID: 23975476.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    85. Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, Uganda. J Clin Pharmacol. 2014 Feb; 54(2):121-32. Bartelink IH, Savic RM, Mwesigwa J, Achan J, Clark T, Plenty A, Charlebois E, Kamya M, Young SL, Gandhi M, Havlir D, Cohan D, Aweeka F. PMID: 24038035.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    86. Hair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeeding. . 2013 Aug 15; 63(5):578-84. Gandhi M, Mwesigwa J, Aweeka F, Plenty A, Charlebois E, Ruel TD, Huang Y, Clark T, Ades V, Natureeba P, Luwedde FA, Achan J, Kamya MR, Havlir DV, Cohan D. PMID: 24135775.
      View in: PubMed   Mentions:
    87. Acceptability and feasibility of serial HIV antibody testing during pregnancy/postpartum and male partner testing in Tororo, Uganda. AIDS Care. 2014; 26(3):360-6. Kim LH, Arinaitwe E, Nzarubara B, Kamya MR, Clark TD, Okong P, Charlebois ED, Havlir DV, Cohan D. PMID: 23909832.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    88. High retention in care among HIV-infected patients entering care with CD4 levels >350 cells/µL under routine program conditions in Uganda. Clin Infect Dis. 2013 Nov; 57(9):1343-50. Namusobya J, Semitala FC, Amanyire G, Kabami J, Chamie G, Bogere J, Jain V, Clark TD, Charlebois E, Havlir DV, Kamya M, Geng EH. PMID: 23899683.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    89. Neonatal mortality in HIV-exposed infants born to women receiving combination antiretroviral therapy in Rural Uganda. J Trop Pediatr. 2013 Dec; 59(6):441-6. Ades V, Mwesigwa J, Natureeba P, Clark TD, Plenty A, Charlebois E, Achan J, Kamya MR, Havlir DV, Cohan D, Ruel TD. PMID: 23764539.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    90. Household ventilation and tuberculosis transmission in Kampala, Uganda. Int J Tuberc Lung Dis. 2013 Jun; 17(6):764-70. Chamie G, Wandera B, Luetkemeyer A, Bogere J, Mugerwa RD, Havlir DV, Charlebois ED. PMID: 23676159.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    91. Improved employment and education outcomes in households of HIV-infected adults with high CD4 cell counts: evidence from a community health campaign in Uganda. AIDS. 2013 Feb 20; 27(4):627-34. Thirumurthy H, Chamie G, Jain V, Kabami J, Kwarisiima D, Clark TD, Geng E, Petersen ML, Charlebois ED, Kamya MR, Havlir DV. PMID: 23169332.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    92. Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies. Am J Trop Med Hyg. 2013 Apr; 88(4):744-6. Ikilezi G, Achan J, Kakuru A, Ruel T, Charlebois E, Clark TD, Rosenthal PJ, Havlir D, Kamya MR, Dorsey G. PMID: 23358639.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    93. 737: Acceptability of serial HIV testing and partner testing during pregnancy and lactation in Tororo, Uganda. American Journal of Obstetrics and Gynecology. 2013 Jan 1; 208(1):s310. Lena Kim, Emmanuel Arinaitwe, Bridget Nzarubara, Tamara Clark, Pius Okong, Edwin Charlebois, Diane Havlir, Deborah Cohan. .
      View in: Publisher Site   Mentions:
    94. Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method. Clin Infect Dis. 2013 Feb; 56(4):598-605. Jain V, Liegler T, Kabami J, Chamie G, Clark TD, Black D, Geng EH, Kwarisiima D, Wong JK, Abdel-Mohsen M, Sonawane N, Aweeka FT, Thirumurthy H, Petersen ML, Charlebois ED, Kamya MR, Havlir DV. PMID: 23243180.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    95. Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children. N Engl J Med. 2012 Nov 29; 367(22):2110-8. Achan J, Kakuru A, Ikilezi G, Ruel T, Clark TD, Nsanzabana C, Charlebois E, Aweeka F, Dorsey G, Rosenthal PJ, Havlir D, Kamya MR. PMID: 23190222.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansPHPublic Health
    96. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda. PLoS One. 2012; 7(8):e43400. Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, Petersen ML, Thirumurthy H, Kamya MR, Havlir DV, Charlebois ED. PMID: 22916256.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    97. Maternal nutritional status predicts adverse birth outcomes among HIV-infected rural Ugandan women receiving combination antiretroviral therapy. PLoS One. 2012; 7(8):e41934. Young S, Murray K, Mwesigwa J, Natureeba P, Osterbauer B, Achan J, Arinaitwe E, Clark T, Ades V, Plenty A, Charlebois E, Ruel T, Kamya M, Havlir D, Cohan D. PMID: 22879899.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    98. Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. Am J Public Health. 2013 Feb; 103(2):308-15. Tsai AC, Karasic DH, Hammer GP, Charlebois ED, Ragland K, Moss AR, Sorensen JL, Dilley JW, Bangsberg DR. PMID: 22720766.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    99. Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts. Clin Infect Dis. 2012 Apr; 54(7):1001-9. Ruel TD, Boivin MJ, Boal HE, Bangirana P, Charlebois E, Havlir DV, Rosenthal PJ, Dorsey G, Achan J, Akello C, Kamya MR, Wong JK. PMID: 22308272.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    100. Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia. . 2011 Nov 01; 58(3):e96-9. Luetkemeyer AF, Charlebois ED, Hare CB, Black D, Smith A, Havlir DV, Peters MG. PMID: 22005002.
      View in: PubMed   Mentions:
    101. A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4? T-cell counts of = 350 cells/µL. J Infect Dis. 2011 Sep 15; 204(6):884-92. Nanteza MW, Mayanja-Kizza H, Charlebois E, Srikantiah P, Lin R, Mupere E, Mugyenyi P, Boom WH, Mugerwa RD, Havlir DV, Whalen CC. PMID: 21849285.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    102. Reply to Wilson et al. Clinical Infectious Diseases. 2011 Sep 15; 53(6):612-613. Edwin D. Charlebois, Moupali Das, Travis C. Porco, Diane V. Havlir. .
      View in: Publisher Site   Mentions:
    103. Sex differences in HIV RNA level and CD4 cell percentage during childhood. Clin Infect Dis. 2011 Sep; 53(6):592-9. Ruel TD, Zanoni BC, Ssewanyana I, Cao H, Havlir DV, Kamya M, Achan J, Charlebois ED, Feeney ME. PMID: 21840929.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    104. Responding to the National HIV/AIDS Strategy-setting the research agenda. . 2011 Jul 01; 57(3):175-80. Morin SF, Kelly JA, Charlebois ED, Remien RH, Rotheram-Borus MJ, Cleary PD. PMID: 21606844.
      View in: PubMed   Mentions:
    105. The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco. Clin Infect Dis. 2011 Apr 15; 52(8):1046-9. Charlebois ED, Das M, Porco TC, Havlir DV. PMID: 21460322.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    106. Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3. J Infect Dis. 2011 Apr 01; 203(7):992-1001. Lancioni CL, Mahan CS, Johnson DF, Walusimbi M, Chervenak KA, Nalukwago S, Charlebois E, Havlir D, Mayanja-Kizza H, Whalen CC, Boom WH. PMID: 21402550.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    107. Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization. . 2011 Feb 01; 56(2):146-50. Carrico AW, Riley ED, Johnson MO, Charlebois ED, Neilands TB, Remien RH, Lightfoot MA, Steward WT, Weinhardt LS, Kelly JA, Rotheram-Borus MJ, Morin SF, Chesney MA. PMID: 21116186.
      View in: PubMed   Mentions:
    108. Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children. . 2011 Jan 01; 56(1):44-50. Ruel TD, Kamya MR, Li P, Pasutti W, Charlebois ED, Liegler T, Dorsey G, Rosenthal PJ, Havlir DV, Wong JK, Achan J. PMID: 21099693.
      View in: PubMed   Mentions:
    109. Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy. . 2010 Nov; 55(3):330-5. Charlebois ED, Ruel TD, Gasasira AF, Achan J, Kateera F, Akello C, Cao H, Dorsey G, Rosenthal PJ, Ssewanyana I, Kamya MR, Havlir DV. PMID: 20592617.
      View in: PubMed   Mentions:
    110. Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. Int J Tuberc Lung Dis. 2010 Oct; 14(10):1295-302. Chamie G, Luetkemeyer A, Walusimbi-Nanteza M, Okwera A, Whalen CC, Mugerwa RD, Havlir DV, Charlebois ED. PMID: 20843421.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    111. "A bird in the hand...": a commentary on the test and treat approach for HIV. Arch Intern Med. 2010 Aug 09; 170(15):1354-6. Charlebois ED, Havlir DV. PMID: 20696961.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    112. Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count. Clin Infect Dis. 2010 Aug 01; 51(3):359-62. Chamie G, Charlebois ED, Srikantiah P, Walusimbi-Nanteza M, Mugerwa RD, Mayanja H, Okwera A, Whalen CC, Havlir DV. PMID: 20569064.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    113. Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS. 2010 Jul 31; 24(12):1945-52. Bebell LM, Pilcher CD, Dorsey G, Havlir D, Kamya MR, Busch MP, Dunn Williams J, Nugent CT, Bentsen C, Rosenthal PJ, Charlebois ED. PMID: 20543656.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    114. Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance. Malar J. 2010 Jun 23; 9:177. Gasasira AF, Kamya MR, Ochong EO, Vora N, Achan J, Charlebois E, Ruel T, Kateera F, Meya DN, Havlir D, Rosenthal PJ, Dorsey G. PMID: 20573194.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimals
    115. HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS. 2010 May 15; 24(8):1163-70. Boivin MJ, Ruel TD, Boal HE, Bangirana P, Cao H, Eller LA, Charlebois E, Havlir DV, Kamya MR, Achan J, Akello C, Wong JK. PMID: 20425886.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    116. Tuberculosis as part of the natural history of HIV infection in developing countries. Clin Infect Dis. 2010 May 15; 50 Suppl 3:S245-54. Chamie G, Luetkemeyer A, Charlebois E, Havlir DV. PMID: 20397955.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    117. Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count. PLoS One. 2010 Feb 22; 5(2):e9138. Mahan CS, Walusimbi M, Johnson DF, Lancioni C, Charlebois E, Baseke J, Chervenak KA, Mugerwa RD, Havlir DV, Mayanja-Kizza H, Whalen CC, Boom WH. PMID: 20179751.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    118. Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers. . 2009 Aug 01; 51(4):424-9. German P, Parikh S, Lawrence J, Dorsey G, Rosenthal PJ, Havlir D, Charlebois E, Hanpithakpong W, Lindegardh N, Aweeka FT. PMID: 19506482.
      View in: PubMed   Mentions:
    119. Patient perspectives with abbreviated versus standard pre-test HIV counseling in the prenatal setting: a randomized-controlled, non-inferiority trial. PLoS One. 2009; 4(4):e5166. Cohan D, Gomez E, Greenberg M, Washington S, Charlebois ED. PMID: 19367335.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    120. Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children. Clin Immunol. 2009 Jun; 131(3):410-4. Ruel T, Ssewanyana I, Achan J, Gasasira A, Kamya MR, Kekitiinwa A, Wong JK, Cao H, Havlir D, Charlebois ED. PMID: 19303366.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    121. Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis. Clin Infect Dis. 2009 Mar 15; 48(6):725-32. Davis JL, Huang L, Kovacs JA, Masur H, Murray P, Havlir DV, Worodria WO, Charlebois ED, Srikantiah P, Cattamanchi A, Huber C, Shea YR, Chow Y, Fischer SH. PMID: 19207077.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    122. The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda. AIDS Res Hum Retroviruses. 2009 Jan; 25(1):65-71. Ssewanyana I, Baker CA, Ruel T, Bousheri S, Kamya M, Dorsey G, Rosenthal PJ, Charlebois E, Havlir D, Cao H. PMID: 19182922.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    123. A behavioral intervention reduces HIV transmission risk by promoting sustained serosorting practices among HIV-infected men who have sex with men. . 2008 Dec 15; 49(5):544-51. Morin SF, Shade SB, Steward WT, Carrico AW, Remien RH, Rotheram-Borus MJ, Kelly JA, Charlebois ED, Johnson MO, Chesney MA. PMID: 18989221.
      View in: PubMed   Mentions:
    124. Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand. . 2008 Dec 01; 49(4):422-31. Khumalo-Sakutukwa G, Morin SF, Fritz K, Charlebois ED, van Rooyen H, Chingono A, Modiba P, Mrumbi K, Visrutaratna S, Singh B, Sweat M, Celentano DD, Coates TJ. PMID: 18931624.
      View in: PubMed   Mentions:
    125. Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis. . 2008 Dec 01; 49(4):458-60. Srikantiah P, Wong JK, Liegler T, Walusimbi M, Mayanja-Kizza H, Kayanja HK, Mugerwa RD, Charlebois ED, Boom WH, Whalen CC, Havlir DV. PMID: 19011423.
      View in: PubMed   Mentions:
    126. HIV RNA suppression among HIV-infected Ugandan children with measles. . 2008 Jun 01; 48(2):225-7. Ruel TD, Achan J, Gasasira AF, Charlebois ED, Mehbratu T, Rosenthal PJ, Dorsey G, Kamya MR, Kekitiinwa A, Wong J, Havlir DV. PMID: 18520684.
      View in: PubMed   Mentions:
    127. Receipt of prevention services among HIV-infected men who have sex with men. Am J Public Health. 2008 Jun; 98(6):1011-4. Steward WT, Charlebois ED, Johnson MO, Remien RH, Goldstein RB, Wong FL, Morin SF. PMID: 18445790.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    128. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Clin Infect Dis. 2008 Apr 01; 46(7):985-91. Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango JN, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal PJ, Havlir D, Dorsey G. PMID: 18444813.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    129. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: the healthy living project randomized controlled study. . 2007 Dec 15; 46(5):574-80. Johnson MO, Charlebois E, Morin SF, Remien RH, Chesney MA. PMID: 18193499.
      View in: PubMed   Mentions:
    130. HIV-1 infection in patients referred for malaria blood smears at government health clinics in Uganda. . 2007 Dec 15; 46(5):624-30. Bebell LM, Gasasira A, Kiggundu M, Dokomajilar C, Kamya MR, Charlebois ED, Havlir D, Rosenthal PJ, Dorsey G. PMID: 18043317.
      View in: PubMed   Mentions:
    131. Profile of T cell immune responses in HIV-infected children from Uganda. J Infect Dis. 2007 Dec 01; 196(11):1667-70. Ssewanyana I, Elrefaei M, Dorsey G, Ruel T, Jones NG, Gasasira A, Kamya M, Nakiwala J, Achan J, Charlebois E, Havlir D, Cao H. PMID: 18008251.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    132. Affect regulation, stimulant use, and viral load among HIV-positive persons on anti-retroviral therapy. Psychosom Med. 2007 Nov; 69(8):785-92. Carrico AW, Johnson MO, Moskowitz JT, Neilands TB, Morin SF, Charlebois ED, Steward WT, Remien RH, Wong FL, Rotheram-Borus MJ, Lightfoot MA, Chesney MA. PMID: 17942835.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    133. Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children. AIDS. 2007 Oct 01; 21(15):2059-66. Kamya MR, Gasasira AF, Achan J, Mebrahtu T, Ruel T, Kekitiinwa A, Charlebois ED, Rosenthal PJ, Havlir D, Dorsey G. PMID: 17885296.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    134. Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda. AIDS. 2007 Sep 12; 21(14):1972-4. Srikantiah P, Walusimbi MN, Kayanja HK, Mayanja-Kizza H, Mugerwa RD, Lin R, Charlebois ED, Boom WH, Whalen CC, Havlir DV. PMID: 17721107.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    135. It's not just what you say: relationships of HIV dislosure and risk reduction among MSM in the post-HAART era. AIDS Care. 2007 Jul; 19(6):749-56. Klitzman R, Exner T, Correale J, Kirshenbaum SB, Remien R, Ehrhardt AA, Lightfoot M, Catz SL, Weinhardt LS, Johnson MO, Morin SF, Rotheram-Borus MJ, Kelly JA, Charlebois E. PMID: 17573594.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    136. Correlates of suicidal ideation among HIV-positive persons. AIDS. 2007 May 31; 21(9):1199-203. Carrico AW, Johnson MO, Morin SF, Remien RH, Charlebois ED, Steward WT, Chesney MA. PMID: 17502730.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    137. Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz. Clin Infect Dis. 2007 Mar 15; 44(6):889-91. German P, Greenhouse B, Coates C, Dorsey G, Rosenthal PJ, Charlebois E, Lindegardh N, Havlir D, Aweeka FT. PMID: 17304470.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    138. Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention. Int J Tuberc Lung Dis. 2007 Feb; 11(2):168-74. Srikantiah P, Lin R, Walusimbi M, Okwera A, Luzze H, Whalen CC, Boom WH, Havlir DV, Charlebois ED. PMID: 17263287.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    139. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med. 2007 Apr 01; 175(7):737-42. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV. PMID: 17218620.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    140. Inappropriate antibiotic use in soft tissue infections. Arch Surg. 2006 Sep; 141(9):850-4; discussion 855-6. Paydar KZ, Hansen SL, Charlebois ED, Harris HW, Young DM. PMID: 16983028.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    141. False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria. J Clin Microbiol. 2006 Aug; 44(8):3021-4. Gasasira AF, Dorsey G, Kamya MR, Havlir D, Kiggundu M, Rosenthal PJ, Charlebois ED. PMID: 16891532.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    142. Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2006 Jun; 10(6):605-12. Johnson JL, Hadad DJ, Boom WH, Daley CL, Peloquin CA, Eisenach KD, Jankus DD, Debanne SM, Charlebois ED, Maciel E, Palaci M, Dietze R. PMID: 16776446.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    143. Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model. AIDS Patient Care STDS. 2006 Apr; 20(4):258-68. Johnson MO, Chesney MA, Goldstein RB, Remien RH, Catz S, Gore-Felton C, Charlebois E, Morin SF. PMID: 16623624.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    144. Antiretroviral therapy and TB. Trop Doct. 2006 Apr; 36(2):73-9. Swaminathan S, Luetkemeyer A, Srikantiah P, Lin R, Charlebois E, Havlir DV. PMID: 16611437.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    145. Removing barriers to knowing HIV status: same-day mobile HIV testing in Zimbabwe. . 2006 Feb 01; 41(2):218-24. Morin SF, Khumalo-Sakutukwa G, Charlebois ED, Routh J, Fritz K, Lane T, Vaki T, Fiamma A, Coates TJ. PMID: 16394855.
      View in: PubMed   Mentions:
    146. HIV surveillance in theory and practice: assessing the acceptability of California's non-name HIV surveillance regulations. Health Policy. 2006 Aug 22; 78(1):101-10. Koester KA, Maiorana A, Vernon K, Charlebois E, Gaffney S, Lane T, Morin SF. PMID: 16256243.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    147. Predicting HIV transmission risk among HIV-infected men who have sex with men: findings from the healthy living project. . 2005 Oct 01; 40(2):226-35. Morin SF, Steward WT, Charlebois ED, Remien RH, Pinkerton SD, Johnson MO, Rotheram-Borus MJ, Lightfoot M, Goldstein RB, Kittel L, Samimy-Muzaffar F, Weinhardt L, Kelly JA, Chesney MA. PMID: 16186742.
      View in: PubMed   Mentions:
    148. Reply. Annals of Emergency Medicine. 2005 Oct 1; 46(4):386. Bradley W. Frazee, Edwin D. Charlebois. .
      View in: Publisher Site   Mentions:
    149. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus--and their relation to community-associated disease activity. J Infect Dis. 2005 Sep 01; 192(5):811-8. Pan ES, Diep BA, Charlebois ED, Auerswald C, Carleton HA, Sensabaugh GF, Perdreau-Remington F. PMID: 16088830.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    150. Potential deterrent effect of name-based HIV infection surveillance. . 2005 Jun 01; 39(2):219-27. Charlebois ED, Maiorana A, McLaughlin M, Koester K, Gaffney S, Rutherford GW, Morin SF. PMID: 15905740.
      View in: PubMed   Mentions:
    151. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med. 2005 Mar; 45(3):311-20. Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F. PMID: 15726056.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCells
    152. Perceived adverse effects of antiretroviral therapy. J Pain Symptom Manage. 2005 Feb; 29(2):193-205. Johnson MO, Charlebois E, Morin SF, Catz SL, Goldstein RB, Remien RH, Rotheram-Borus MJ, Mickalian JD, Kittel L, Samimy-Muzaffar F, Lightfoot MA, Gore-Felton C, Chesney A. PMID: 15793937.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    153. HIV seroconversion among the homeless and marginally housed in San Francisco: a ten-year study. . 2004 Dec 15; 37(5):1616-9. Hahn JA, Bangsberg DR, McFarland W, Charlebois ED, Clark RA, Moss AR. PMID: 15577419.
      View in: PubMed   Mentions:
    154. Rapid increase in tuberculosis incidence soon after infection with HIV--a new twist in the twin epidemics. J Infect Dis. 2005 Jan 15; 191(2):147-9. Srikantiah P, Charlebois E, Havlir DV. PMID: 15609222.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    155. Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci. Am J Infect Control. 2004 Dec; 32(8):462-9. Winston LG, Charlebois ED, Pang S, Bangsberg DR, Perdreau-Remington F, Chambers HF. PMID: 15573053.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    156. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis. 2004 Nov 15; 190(10):1730-8. Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F. PMID: 15499526.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    157. Written clinic procedures enhance delivery of HIV "prevention with positives" counseling in primary health care settings. . 2004 Oct 01; 37 Suppl 2:S95-S100. Myers JJ, Steward WT, Charlebois E, Koester KA, Maiorana A, Morin SF. PMID: 15385905.
      View in: PubMed   Mentions:
    158. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis. 2004 Oct 15; 39(8):1190-8. Moss AR, Hahn JA, Perry S, Charlebois ED, Guzman D, Clark RA, Bangsberg DR. PMID: 15486844.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    159. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg. 2004 Sep; 139(9):947-51; discussion 951-3. Young DM, Harris HW, Charlebois ED, Chambers H, Campbell A, Perdreau-Remington F, Lee C, Mankani M, Mackersie R, Schecter WP. PMID: 15381611.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCellsPHPublic Health
    160. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. . 2004 Aug 15; 36(5):1100-2. Oyugi JH, Byakika-Tusiime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, Bangsberg DR. PMID: 15247564.
      View in: PubMed   Mentions:
    161. Prevalence of antiretroviral drug resistance in the HIV-1-infected urban indigent population in San Francisco: a representative study. Int J STD AIDS. 2004 Aug; 15(8):543-51. Holodniy M, Charlebois ED, Bangsberg DR, Zolopa AR, Schulte M, Moss AR. PMID: 15307966.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    162. HIV seroprevalence among homeless and marginally housed adults in San Francisco. Am J Public Health. 2004 Jul; 94(7):1207-17. Robertson MJ, Clark RA, Charlebois ED, Tulsky J, Long HL, Bangsberg DR, Moss AR. PMID: 15226145.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansPHPublic Health
    163. Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates. J Infect Dis. 2004 Jul 01; 190(1):162-5. Bangsberg DR, Porco TC, Kagay C, Charlebois ED, Deeks SG, Guzman D, Clark R, Moss A. PMID: 15195256.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    164. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2004 Jul 01; 39(1):47-54. Charlebois ED, Perdreau-Remington F, Kreiswirth B, Bangsberg DR, Ciccarone D, Diep BA, Ng VL, Chansky K, Edlin BR, Edlin B, Chambers HF. PMID: 15206052.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    165. Modeling the impact of modified directly observed antiretroviral therapy on HIV suppression and resistance, disease progression, and death. Clin Infect Dis. 2004 Jun 01; 38 Suppl 5:S414-20. Kagay CR, Porco TC, Liechty CA, Charlebois E, Clark R, Guzman D, Moss AR, Bangsberg DR. PMID: 15156432.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    166. Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med. 2004 Apr; 19(4):357-65. Hall CS, Charlebois ED, Hahn JA, Moss AR, Bangsberg DR. PMID: 15061745.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    167. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004 Mar-Apr; 5(2):74-9. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. PMID: 15116282.
      View in: PubMed   Mentions: 152     Fields:    Translation:Humans
    168. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004 Jan 02; 18(1):81-8. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. PMID: 15090833.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    169. Are untimed antiretroviral drug levels useful predictors of adherence behavior? AIDS. 2004 Jan 02; 18(1):127-9. Liechty CA, Alexander CS, Harrigan PR, Guzman JD, Charlebois ED, Moss AR, Bangsberg DR. PMID: 15090840.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    170. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project. AIDS Patient Care STDS. 2003 Dec; 17(12):645-56. Johnson MO, Catz SL, Remien RH, Rotheram-Borus MJ, Morin SF, Charlebois E, Gore-Felton C, Goldsten RB, Wolfe H, Lightfoot M, Chesney MA. PMID: 14746658.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    171. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis. 2003 Nov 15; 37(10):1384-8. Pan ES, Diep BA, Carleton HA, Charlebois ED, Sensabaugh GF, Haller BL, Perdreau-Remington F. PMID: 14583874.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    172. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS. 2003 Sep 05; 17(13):1925-32. Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, Conroy KN, Clark R, Guzman D, Zolopa A, Moss A. PMID: 12960825.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    173. Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital. Am J Infect Control. 2002 Nov; 30(7):400-6. Winston LG, Bangsberg DR, Chambers HF, Felt SC, Rosen JI, Charlebois ED, Wong M, Steele L, Gerberding JL, Perdreau-Remington F. PMID: 12410216.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    174. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis. 2002 Feb 15; 34(4):425-33. Charlebois ED, Bangsberg DR, Moss NJ, Moore MR, Moss AR, Chambers HF, Perdreau-Remington F. PMID: 11797167.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    175. Comparing Objective Measures of Adherence to HIV Antiretroviral Therapy: Electronic Medication Monitors and Unannounced Pill Counts. AIDS and Behavior. 2001 Sep 1; 5(3):275-281. David R. Bangsberg, Frederick M. Hecht, Edwin D. Charlebois, Margaret Chesney, Andrew Moss. .
      View in: Publisher Site   Mentions:
    176. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet. 2001 Aug 04; 358(9279):368-74. Staedke SG, Kamya MR, Dorsey G, Gasasira A, Ndeezi G, Charlebois ED, Rosenthal PJ. PMID: 11502317.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    177. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001 Jun 15; 15(9):1181-3. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. PMID: 11416722.
      View in: PubMed   Mentions: 324     Fields:    Translation:HumansCells
    178. Provider assessment of adherence to HIV antiretroviral therapy. . 2001 Apr 15; 26(5):435-42. Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A. PMID: 11391162.
      View in: PubMed   Mentions:
    179. Provider Assessment of Adherence to HIV Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2001 Apr 1; 26(5):435-442. David R. Bangsberg, Frederick M. Hecht, Heather Clague, Edwin D. Charlebois, Dan Ciccarone, Margaret Chesney, Andrew Moss. .
      View in: Publisher Site   Mentions:
    180. Provider Assessment of Adherence to HIV Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2001 Apr 1; 26(5):435-442. David R. Bangsberg, Frederick M. Hecht, Heather Clague, Edwin D. Charlebois, Dan Ciccarone, Margaret Chesney, Andrew Moss. .
      View in: Publisher Site   Mentions:
    181. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000 Mar 10; 14(4):357-66. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. PMID: 10770537.
      View in: PubMed   Mentions: 301     Fields:    Translation:HumansCells
    182. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5. J Clin Microbiol. 2000 Mar; 38(3):1113-20. Elbeik T, Charlebois E, Nassos P, Kahn J, Hecht FM, Yajko D, Ng V, Hadley K. PMID: 10699005.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    183. Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine. J Infect Dis. 2000 Jan; 181(1):335-9. Kohl S, Charlebois ED, Sigouroudinia M, Goldbeck C, Hartog K, Sekulovich RE, Langenberg AG, Burke RL. PMID: 10608784.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    184. Expanding access to early HIV care: new challenges for federal health policy. AIDS Public Policy J. 2000; 15(2):65-74. Morin SF, Charlebois ED. PMID: 11519368.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    185. Risk factors for early hospital readmission in patients with AIDS and pneumonia. J Gen Intern Med. 1999 Sep; 14(9):531-6. Grant RW, Charlebois ED, Wachter RM. PMID: 10491241.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    186. Physician-assisted suicide and patients with human immunodeficiency virus disease. N Engl J Med. 1997 Feb 06; 336(6):417-21. Slome LR, Mitchell TF, Charlebois E, Benevedes JM, Abrams DI. PMID: 9010149.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    187. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 1997 Jan; 155(1):60-6. Stansell JD, Osmond DH, Charlebois E, LaVange L, Wallace JM, Alexander BV, Glassroth J, Kvale PA, Rosen MJ, Reichman LB, Turner JR, Hopewell PC. PMID: 9001290.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    188. Bias in observational studies of treatment. Ann Intern Med. 1996 Dec 01; 125(11):941. Osmond DH, Charlebois E, Moss AR. PMID: 8967684.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    189. Interleukin-12 administered in vivo decreases human NK cell cytotoxicity and antibody-dependent cellular cytotoxicity to human immunodeficiency virus-infected cells. J Infect Dis. 1996 Nov; 174(5):1105-8. Kohl S, Sigaroudinia M, Charlebois ED, Jacobson MA. PMID: 8896517.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    190. Off-label drug use in human immunodeficiency virus disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 May 01; 12(1):56-62. Brosgart CL, Mitchell T, Charlebois E, Coleman R, Mehalko S, Young J, Abrams DI. PMID: 8624761.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    191. Cost and Outcome of Intensive Care for Patients with AIDS, Pneumocystis carinii Pneumonia, and Severe Respiratory Failure. Survey of Anesthesiology. 1996 Apr 1; 40(2):75-76. ROBERT M. WACHTER, JOHN M. LUCE, SHARON SAFRIN, DANIEL C. BERRIOS, EDWIN CHARLEBOIS, ANNE A. SCITOVSKY. .
      View in: Publisher Site   Mentions:
    192. Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure. JAMA. 1995 Jan 18; 273(3):230-5. Wachter RM, Luce JM, Safrin S, Berrios DC, Charlebois E, Scitovsky AA. PMID: 7807663.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    193. Continuous low-dose interferon-alpha therapy for HIV-related immune thrombocytopenic purpura. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 01; 8(1):45-50. Northfelt DW, Charlebois ED, Mirda MI, Child C, Kaplan LD, Abrams DI. PMID: 8548345.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    194. Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol. 1994 Oct 15; 140(8):747-58. Veugelers PJ, Page KA, Tindall B, Schechter MT, Moss AR, Winkelstein WW, Cooper DA, Craib KJ, Charlebois E, Coutinho RA. PMID: 7942776.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    195. Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1. J Infect Dis. 1994 Aug; 170(2):308-12. Jenkins M, Landers D, Williams-Herman D, Wara D, Viscarello RR, Hammill HA, Kline MW, Shearer WT, Charlebois ED, Kohl S. PMID: 8035015.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    196. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA. 1994 Apr 13; 271(14):1083-7. Osmond D, Charlebois E, Lang W, Shiboski S, Moss A. PMID: 7908703.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    197. Screening of blood donors for idiopathic CD4+ T-lymphocytopenia. Transfusion. 1994 Mar; 34(3):192-7. Busch MP, Valinsky JE, Paglieroni T, Prince HE, Crutcher GJ, Gjerset GF, Operskalski EA, Charlebois E, Bianco C, Holland PV. PMID: 7908469.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    198. Central venous catheter infections in AIDS patients receiving treatment for cytomegalovirus disease. J Acquir Immune Defic Syndr (1988). 1994 Mar; 7(3):272-8. Stanley HD, Charlebois E, Harb G, Jacobson MA. PMID: 8106966.
      View in: PubMed   Mentions:
    199. Differences in time from HIV seroconversion to CD4+ lymphocyte end-points and AIDS in cohorts of homosexual men. AIDS. 1993 Oct; 7(10):1325-9. Veugelers PJ, Schechter MT, Tindall B, Moss AR, Page KA, Craib KJ, Cooper DA, Coutinho RA, Charlebois E, Winkelstein W. PMID: 7903540.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    200. Antibodies to epitopes of herpes simplex virus type 1 glycoprotein B (gB) in human sera: analysis of functional gB epitopes defined by inhibition of murine monoclonal antibodies. J Infect Dis. 1993 Oct; 168(4):844-53. Sanchez-Pescador L, Pereira L, Charlebois ED, Kohl S. PMID: 7690824.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    201. Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection. J Infect Dis. 1993 Jul; 168(1):112-9. Jacobson MA, Yajko D, Northfelt D, Charlebois E, Gary D, Brosgart C, Sanders CA, Hadley WK. PMID: 8515098.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    202. CD4+ T-lymphocytopenia without HIV infection. N Engl J Med. 1993 Jun 24; 328(25):1847-8. Sheppard H, Winkelstein W, Lang W, Charlebois E. PMID: 8099196.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    203. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis. 1993 Jan; 167(1):66-71. Osmond DH, Charlebois E, Sheppard HW, Page K, Winkelstein W, Moss AR, Reingold A. PMID: 8418184.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    Edwin's Networks
    Concepts (569)
    Derived automatically from this person's publications.
    _
    Co-Authors (96)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _